Please assess the completion status of the following clinical trial:

Trial Title: Preoperative Octreotide Treatment of Acromegaly

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* GH nadir during a standard 75 g OGTT \>= 5.0 mmol/L.~* Pituitary tumor by MRI-scan.~Exclusion Criteria:~* Immediate surgery indicated by usual clinical criteria.~* Pregnant.~* Known adverse effects of octreotide.~* Unfit for participation by any other reason.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- octreotide (Type: EXPERIMENTAL): 6 months preoperative treatment with octreotide before transsphenoidal surgery for acromegaly
- standard surgery (Type: ACTIVE_COMPARATOR): Standard transphenoidal surgery soon after the diagnosis of acromegaly

Based on this trial design, predict the completion outcome and termination type (if applicable).